Induced pluripotent stem cells in Hirschsprung disease: Modeling, mechanisms, and translational challenges
World Journal of Stem Cells · 26.08.2026 · 18 (8)
DOI: 10.4252/wjsc.123046 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Stem Cells, online erschienen am 26.08.2026. Verfasst von Yuan-Xiang Qiu und 7 weiteren Autor:innen. Die Arbeit nennt 128 Literaturangaben.
Abstract (Originalsprache)
Hirschsprung disease (HSCR) is a congenital disorder of the enteric nervous system (ENS) caused by impaired migration, proliferation, survival, and differentiation of enteric neural crest cells (ENCCs) during intestinal development. Although many HSCR-associated genes and regulatory variants have been identified, most cases are oligogenic or multifactorial, and mechanistic studies are limited by scarce human embryonic enteric tissues. Patient-derived induced pluripotent stem cells (iPSCs) preserve individual genetic backgrounds and can be differentiated into ENCCs, enteric neurons, and intestinal or colonic organoids, providing human platforms for modeling early ENS development and disease-relevant phenotypes. This review summarizes iPSC platform establishment, ENCC differentiation, two-dimensional ENCC models, recombined or co-culture organoids, emerging bioengineered gut systems, drug screening, and regenerative strategies. We discuss how genetic complexity, isogenic controls, multi-omics integration, electrophysiological maturation, and ENCC-microenvironment interactions influence model interpretation. Current applications remain limited by developmental immaturity, inter-line and inter-batch variability, incomplete functional validation, safety concerns, manufacturing requirements, and pediatric regulatory considerations. At present, iPSC-based HSCR models are best viewed as complementary tools for mechanistic investigation and preclinical development rather than direct routes to clinical therapy.
Zitieren
APA
Qiu, Y., Zhi, Z., Leng, Y., Zhang, X., Du, C., Tang, J., Li, H., & Tang, W. (2026). Induced pluripotent stem cells in Hirschsprung disease: Modeling, mechanisms, and translational challenges. World Journal of Stem Cells, 18(8). https://doi.org/10.4252/wjsc.123046
Vancouver
Qiu Y, Zhi Z, Leng Y, Zhang X, Du C, Tang J, et al. Induced pluripotent stem cells in Hirschsprung disease: Modeling, mechanisms, and translational challenges. World Journal of Stem Cells. 2026;18(8). doi:10.4252/wjsc.123046
BibTeX
@article{Qiu2026,
author = {Qiu, Yuan-Xiang and Zhi, Zheng-Ke and Leng, Yu-Mu and Zhang, Xin-Tao and Du, Chun-Xia and Tang, Jie and Li, Hong-Xing and Tang, Wei-Bing},
title = {Induced pluripotent stem cells in Hirschsprung disease: Modeling, mechanisms, and translational challenges},
journal = {World Journal of Stem Cells},
year = {2026},
volume = {18},
number = {8},
doi = {10.4252/wjsc.123046}
}
EUVIMED